Data / Form D filings / Metacrine, Inc.
Metacrine, Inc.: Form D filings
Metacrine, Inc., a pharmaceuticals company in San Diego, CA, filed 5 Form D notices with the SEC between 2015 and 2018. The latest, on June 20, 2018, reports $65 million sold of a $65 million offering to 26 investors.
Find out what Metacrine, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3985 Sorrento Valley Blvd., Suite C, San Diego, CA, 92121
- Phone
- (858) 369-7800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1634379
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2018 | New notice | $65,000,000 | $65,000,000 | $0 | 26 | Jun 5, 2018 | sec.gov |
| Dec 13, 2017 | New notice | $22,000,000 | $22,000,000 | $0 | 7 | Nov 30, 2017 | sec.gov |
| Nov 9, 2016 | Amendment | $37,766,644 | $37,766,644 | $0 | 20 | Jan 30, 2015 | sec.gov |
| Oct 6, 2015 | Amendment | $36,449,979 | $12,149,995 | $24,299,984 | 18 | Jan 30, 2015 | sec.gov |
| Apr 13, 2015 | New notice | $33,000,000 | $6,850,000 | $26,150,000 | 5 | Jan 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Adelman | Director | |
| Kristina Burow | Director | |
| Carol Gallagher | Director | |
| Richard Heyman | Director | |
| Patricia Millican | Executive Officer | |
| Kenneth Song | Executive Officer, Director | |
| Ronald Evans | Director | |
| Amir Nashat | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 18, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Metacrine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.